WHO creates data base on use of child medicines

Jun 18, 2010

(AP) -- The World Health Organization on Friday issued its first-ever guidance on how to use more than 240 essential medicines for children under 13.

The data provide information on use, dosage and side effects of medicines as well as warnings about which children should not take them, the U.N. health agency said. The 528-page document also tells users about common drug interactions.

"To be effective, medicines must be carefully chosen and the dose adjusted to suit the age, weight and needs of children," said WHO's Dr Hans Hogerzeil.

"Without a global guide, many have had to prescribe medicines based on very limited evidence," he said in a statement.

Some countries have developed their own instructions for giving medicines to children, but there are no universal standards.

The WHO document only exists in English. But the agency recommends that governments use it as a model and translate it into their national language, spokeswoman Fadela Chaib said.

Around 8.8 million children under 5 die every year, many from diseases such as and that could be avoided with the correct use of medicines, according to WHO.

Explore further: Anti-cholinergic drugs impair physical function in elderly patients

More information: http://bit.ly/a9ttEd

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Report: Children's medicine has additives

Mar 11, 2007

Britain's Food Commission finds most over-the-counter medication for young children contains additives that are banned from food for infants and toddlers.

Recommended for you

FDA to start regulating lab-developed tests

Jul 31, 2014

(AP)—The Food and Drug Administration announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

User comments : 0